論文發表

魏銘洲主任

Ting WH, Chen HH, Hsieh SW, Wei MC, Hsiao SM*. Comparison of Clinical Outcomes in Women with Surgically Treated Early Primary Cervical Cancer: Lymphadenectomy versus Sentinel Lymph Node Biopsy. J Chin Med Assoc. 2025;88(3):238-45. (IF = 1.9; R/C = 104/325)
Ting WH, Chen HH, Wei MC, Sun HD, Hsiao SM*. Intraperitoneal Chemotherapy without Bevacizumab versus Intravenous Chemotherapy with Bevacizumab as the Frontline Adjuvant Therapy in Advanced Ovarian Cancer. Cancers 2024;16(3382):1-11. (IF = 4.5; R/C = 78/322)
Wei MC, Chuang YC*, Lu HF, Liu HM. Creation of retroperitoneal tunnel in robot assisted laparoscopic sacrohysteropexy. Asian J Surg. 2023;46(2):909. (IF = 2.808; R/C = 88/211)
Ting WH#, Hsieh SW#, Chen HH, Wei MC, Lin HH, Hsiao SM*. Predictors for the Recurrence of Clinically Uterine-Confined Endometrial Cancer and the Role of Cytokeratin Immunohistochemistry Stain in the Era of Sentinel Lymph Node Mapping. Cancers 2022;14:1-13. (IF = 6.639; R/C = 51/242)
Chen HH, Ting WH, Sun HD, Wei MC, Lin HH, Hsiao SM*. Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy. Int J Environ Res Public Health. 2020;17(16):e5941:1-15. (IF = 2.849; R/C = 32/170)
Ting WH, Hsiao CH, Chen HH, Wei MC, Lin HH, Hsiao SM*. Comparisons of clinical outcomes in women with advanced ovarian cancer treated with frontline Intraperitoneal versus dose-dense platinum/paclitaxel chemotherapy without bevacizumab. Int.J.Environ.Res.Public Health 2020;17(3603):10.3390 (IF = 2.468; R/C = 67/186)
Ting WH, Hsiao SM, Lin HH, Wei MC. Primary Carcinoid Tumor of the Ovary arising in a Mature Cystic Teratoma: a Case Report. Eur J Gynaecol Oncol 2014;35:100-2.
Chen YY, Hsiao SM, Hsu YP, Lin HH, Wei MC*. Borderline mucinous ovarian tumor Presenting as pseudo-Meigs’ syndrome. J Obstet Gynecol Res. 2013;39:434-6 (SCI)
Hsieh CH, Tien HJ, Hsiao SM, Wei MC, Wu WY, Sun HD, Wang LY, Hsieh YP, Chen YJ, Shueng PW. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result. Onco Targets Ther 2013;6:59-66.
Sun HD, Tsai CC, Hsiao SM, Wei MC, Wang KC, Wang PH. Primary gallbladder carcinoma presenting as advanced-stage ovarian cancer. Taiwan J Obstet Gynecol2012;51:443-5 (SCI)
Cheung WK, Ho MP, Wei MC, Shueng PW, Huang SF. Association between uterine prolapse and cervical squamous cell carcinoma in an elderly adult.J Am Geriatr Soc2012;60:1775-7 (SCI)
Hsieh CH, Shueng PW, Hsiao SM, Wei MC, Wu WY, Sun HD, Tien HJ, Wang LY, Hsieh YP. Helical tomotherapy provides efficacy similar to that of intensity-modulated radiation therapy with dosimetric benefits for endometrial carcinoma. Onco Targets Ther. 2012;5:245-53.
Hsieh CH, Wei MC, Hsu YP, Chong NS, Chen YJ, Hsiao SM, Hsieh YP, Wang LY, Shueng PW^*. Should helical tomotherapy replace brachytherapy for cervical cancer? Case report. BMC Cancer 2010;10: 637 (SCI)
Hsieh CH, Wei MC, Lee HY, Hsiao SM, Chen CA, Wang LY, Hsieh YP, Tsai TH, Chen YJ, Shueng PW. Whole Pelvic Helical Tomotherapy for Locally Advanced Cervical Cancer: Technical implementation of IMRT with Helical Tomothearapy. Radiat Oncol 2009; 4:62. (SCI)
Chien SC, Lo CY, Wei MC*. Rupture of uterine arteriovenous malformation as a cause of severe menorrhagia. Taiwan J Obstet Gynecol 2007;46:314-6 (SCI)
ChienSC, Tseng SC, Hwa HL, Wei MC *. Immediate post-partum haemorrhage caused by rupture of uterine arteriovenous malformation. Aust N Z J Obstet Gynaecol 2007;47:252-4 (SCI)

TOP